Optimizing use of FDA Approved Anti-obesity Medications
CME/CE Expiration Date: 4/25/2024* *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.
This session provides a brief overview of FDA-approved anti-obesity medications (AOM’s). The session includes a series of case presentations exploring medication options in specific patient scenarios.
The Obesity Medicine Association (OMA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians.
The Obesity Medicine Association designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim the credit commensurate with the extent of their participation in the activity.
|Access Date||Quiz Result||Score||Actions|